Table 2.
Cardiovascular medications and in those achieving or not achieving the recommended LDL-C level
| Overall (N = 2009) | LDL-C target not achieved at last available visit (N = 1138) | LDL-C target achieved at last available visit (N = 871) | P | |
|---|---|---|---|---|
| ACE inhibitor | 38.2% | 34.1% | 43.5% | < 0.0001 |
| Angiotensin receptor blockers | 22.4% | 22.9% | 21.8% | 0.58 |
| Beta-blocker | 39.1% | 33.6% | 46.4% | < 0.0001 |
| Calcium channel blocker | 22.4% | 21.1% | 24.0% | 0.12 |
| Diuretic | 19.0% | 20.3% | 17.2% | 0.08 |
| Antiplatelet therapy | 61.3% | 55.5% | 68.8% | < 0.0001 |
| Anticoagulant therapy | 7.2% | 7.2% | 7.2% | 0.98 |
ACE, angiotensin-converting enzyme; LDL-C, low-density lipoprotein cholesterol.